Same Indication

Pembrolizumab vs Yttrium Chloride Y-90

Pembrolizumab vs Yttrium Chloride Y-90: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Yttrium Chloride Y-90.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Pembrolizumab β€” 26 days.

Chemical Properties

Type: Pembrolizumab β€” Antibody; Yttrium Chloride Y-90 β€” Small molecule.